# A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

> **NCT01168310** · PHASE2 · COMPLETED · sponsor: **Dey** · enrollment: 468 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Fluticasone Propionate/Formoterol Fumarate
- **DRUG:** Fluticasone Propionate/Formoterol Fumarate
- **DRUG:** Fluticasone Propionate/Formoterol Fumarate
- **DRUG:** Fluticasone Propionate/Formoterol Fumarate
- **DRUG:** Fluticasone Propionate/Formoterol Fumarate
- **DRUG:** Formoterol Fumarate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01168310
- **Lead sponsor:** Dey
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-08
- **Final completion:** 2011-10
- **Target enrollment:** 468 (ACTUAL)
- **Last updated:** 2013-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01168310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01168310, "A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01168310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*